Real Life Safety and Efficacy of Vardenafil

• Status: Terminated
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: Male

Summary

In this uncontrolled, non-randomized, prospective, local post-marketed surveillance study, data are obtained on safety and efficacy of LEVITRA® in routine treatment of erectile dysfunction. The general objectives are to evaluate the product safety (primarily by recording adverse events), efficacy and patient acceptance.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Vardenafil Dihydrochloride

Criteria

Inclusion Criteria:

• Any adult patient (>/=18 years) with erectile dysfunction treated with LEVITRA®.

• Patients must be able to give written informed consent for participation in the study after receiving detailed written and oral information prior to the study.

Exclusion Criteria:

• Exclusion criteria must be read in conjunction with the product information (Package Insert).